Kidney Transplant
📧 Sign up to get email alerts when something new happens for Kidney Transplant.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients [Phase 2]
A Phase 2 trial evaluating sodium bicarbonate (Nephrotrans) for calcification propensity in kidney transplant recipients has been withdrawn.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: StOPping Hypertension and imprOving Children's Lives After KidnEy TranSplantation [NA]
Status update for a pediatric kidney transplantation trial aiming to stop hypertension; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR. [EARLY_Phase 1]
A Phase 1 study from Yale assessed cognitive function in kidney transplant patients before and after converting from immediate-release tacro…
-
FDA approval · 2024-05-29FDA Approved: MYCOPHENOLIC ACID — Original Application (Novugen Pharma (USA) LLC.)
FDA approved an original application for mycophenolic acid, enabling a generic version of the immunosuppressant used to prevent organ transp…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Progressive Relaxation Exercises for Kidney Donors [NA]
This clinical trial update from Fenerbahce University assesses progressive relaxation exercises for kidney donors to address transplantation…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-04-08FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
FDA approved a supplemental application for ENVARSUS XR (tacrolimus extended-release) submitted by Veloxis Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects [Phase 4]
Phase 4 trial evaluating immunosuppressive drugs and gut microbiome effects on pharmacokinetics and microbiome diversity in kidney transplan…
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Postoperative Pain Control Following Renal Transplant [Phase 4]
Phase 4 clinical trial update on postoperative pain control after kidney transplant; the study was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients [Phase 2]
Phase 2 trial updating efficacy and safety of imlifidase for antibody-mediated rejection in kidney transplant patients has completed with re…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant [Phase 2]
Phase 2 multicenter trial assessing the effect of AAT on islet transplant engraftment and durability after renal transplant has completed an…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial [NA]
Completed clinical trial focusing on adherence in adolescents with spina bifida and kidney transplant patients; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients [Phase 4]
Phase 4 clinical trial comparing mizoribine with mycophenolate mofetil for immunosuppression in living-related kidney transplant recipients;…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation [Phase 3]
Phase 3 trial update evaluating pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus in paediatric kidney trans…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation [Phase 4]
Phase 4 clinical trial comparing tacrolimus/sirolimus, tacrolimus/mycophenolate mofetil (MMF), and Neoral/sirolimus in adult primary kidney …
-
FDA approval · 2023-09-18FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Accord Healthcare's generic mycophenolate mofetil, supporting its use to prevent organ trans…
-
FDA approval · 2023-09-14FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
FDA approved a supplemental application for ENVARSUS XR (tacrolimus) from Veloxis Pharmaceuticals, Inc., typically affecting the product's l…
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients [Phase 4]
Phase 4 trial update on dosing strategies for de novo once-daily extended-release tacrolimus (LCPT) in kidney transplant recipients, with re…
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation [Phase 4]
Phase 4 clinical trial comparing sirolimus, everolimus, and mycophenolate in kidney transplant recipients; results completed with posted res…
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: GastroIntestinal Panel in Kidney Transplant Patients [Phase 3]
Phase 3 clinical trial update on a GastroIntestinal Panel in kidney transplant patients, with conditions including kidney transplant complic…
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Envarsus XR® in Adolescent Renal Transplant Recipients [Phase 4]
Phase 4 clinical trial update for Envarsus XR in adolescent kidney transplant recipients (active not recruiting).
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Effect of Moderate Caloric Restriction on Glomerular Growth After Kidney Transplantation [NA]
A terminated clinical trial investigating the effect of moderate caloric restriction on glomerular growth after kidney transplantation; resu…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: The POWERED Study: Prophylaxis With Metformin to Prevent PTDM [Phase 2]
Phase 2 trial update on using metformin prophylaxis to prevent post-transplant diabetes mellitus after kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Effects of Dexmedetomidine on Microcirculation and Residual Kidney Function in Kidney Donors [Phase 4]
Phase 4 clinical trial investigating the effects of dexmedetomidine on microcirculation and residual kidney function in kidney donors.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients [Phase 1, Phase 2]
First-in-human induction treatment LIS1 studied in kidney transplant recipients; completed phase 1/2 trial.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Effects of Inhibiting Early Inflammation in Kidney Transplant Patients [Phase 2]
Phase 2 trial investigating the effects of inhibiting early inflammation in kidney transplant patients has completed with results posted.